Relogen Cancer Paramarsh Private Limited

Founded in 2024 and headquartered in Uttar Pradesh, India.

2024 | Varanasi, Uttar Pradesh (India) | Active
Last Updated:

Relogen Cancer Paramarsh Profile

Key Indicators

  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Months 18 Days

About Relogen Cancer Paramarsh

Relogen Cancer Paramarsh Private Limited (RCPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 June 2024 ( nine months 18 days old ). Its registered office is in Varanasi, Uttar Pradesh, India.

The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Uday Shahi and Archana Shahi serve as directors at the Company.

Company Details

  • Location

    Varanasi, Uttar Pradesh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U86100UP2024PTC204578

  • Company No.

    204578

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    13 Jun 2024

  • Date of AGM

    -

  • Date of Balance Sheet

    -

  • Listing Status

    Unlisted

  • ROC Code

    Roc Kanpur

Who are the key members and board of directors at Relogen Cancer Paramarsh?

Board Members (2)

NameDesignationAppointment DateStatus
Uday Shahi Country flag representing In Director 13-Jun-2024Current
Archana Shahi Country flag representing In Director 13-Jun-2024Current

Financial Performance of Relogen Cancer Paramarsh.

Enhance accessibility to Relogen Cancer Paramarsh's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Relogen Cancer Paramarsh revenue growth over time
Relogen Cancer Paramarsh profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Relogen Cancer Paramarsh?

Unlock access to Relogen Cancer Paramarsh's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Relogen Cancer Paramarsh?

Unlock and access historical data on people associated with Relogen Cancer Paramarsh, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Relogen Cancer Paramarsh Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Relogen Cancer Paramarsh, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relogen Cancer Paramarsh's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Relogen Cancer Paramarsh

Recent activity within the organization

  • Director Appointment

    Uday Pratap Shahi was appointed as a Director was appointed as a Director on 13 Jun 2024 & has been associated with this company since 9 months 18 days .

  • Director Appointment

    Archana Shahi was appointed as a Director was appointed as a Director on 13 Jun 2024 & has been associated with this company since 9 months 18 days .

  • Company Incorporation

    Relogen Cancer Paramarsh Private Limited was registered on 13 Jun 2024 with Roc Kanpur & aged 9 months 18 days as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Relogen Cancer Paramarsh Private Limited?

    Relogen Cancer Paramarsh Private Limited was incorporated on 13 Jun 2024.

  • What is authorized share capital and paid-up capital of Relogen Cancer Paramarsh Private Limited?

    The authorized share capital of Relogen Cancer Paramarsh Private Limited is ₹ 1.50 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Relogen Cancer Paramarsh Private Limited?

    Currently 2 directors are associated with Relogen Cancer Paramarsh Private Limited.

    • Uday Pratap Shahi
    • Archana Shahi
  • What is the registered address of Relogen Cancer Paramarsh Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Relogen Cancer Paramarsh Private Limited is C/O. Uday Pratap Shahi Gautam Nagar, Susuwahi India, Varanasi, Uttar Pradesh, 221011.

  • What is the corporate identification number (CIN) and company number of Relogen Cancer Paramarsh Private Limited?

    The corporate identification number (CIN) of Relogen Cancer Paramarsh Private Limited is U86100UP2024PTC204578 and the company number is 204578 as per Ministry of Corporate Affairs (MCA).